Janetta Trochimiuk - 30 Sep 2021 Form 3 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Principal Accounting Officer
Signature
/s/ Janetta Trochimiuk
Issuer symbol
PDSB
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
3
Filing time
12 Oct 2021, 16:30:17 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PDSB Stock Option (Right to Buy) 30 Sep 2021 Common Stock 10,000 $2.88 Direct F1
holding PDSB Stock Option (Right to Buy) 30 Sep 2021 Common Stock 5,000 $1.45 Direct F2
holding PDSB Stock Option (Right to Buy) 30 Sep 2021 Common Stock 27,750 $2.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on December 9, 2019, with 25% vesting on December 9, 2020 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F2 The option was granted on June 23, 2020, with 25% vesting on June 23, 2020 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F3 The option was granted on December 8, 2020, with 25% vesting on December 8, 2021 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.